Brugos-Larumbe Antonio, Aldaz-Herce Pablo, Guillen-Grima Francisco, Garjón-Parra Francisco Javier, Bartolomé-Resano Francisco Javier, Arizaleta-Beloqui María Teresa, Pérez-Ciordia Ignacio, Fernández-Navascués Ana María, Lerena-Rivas María José, Berjón-Reyero Jesús, Jusué-Rípodas Luisa, Aguinaga-Ontoso Ines
Primary Health Care, Navarra Health Service, Pamplona, Navarra, Spain.
Dept. of Health Sciences, Public University of Navarra, Preventive Medicine University of Navarra Clinic, IdiSNA (Navarra Institute for Health Research), Pamplona, Navarra, Spain.
Prim Care Diabetes. 2018 Feb;12(1):34-44. doi: 10.1016/j.pcd.2017.06.008. Epub 2017 Jul 18.
Assess compliance with the IDF recommendations for patients with Diabetes Type2 (DM2), and its variability, by groups of doctors and nurses who provide primary care services in Navarre (Spain).
A cross-sectional study of a population of 462,568 inhabitants, aged ≥18 years in 2013, attended by 381 units of doctor/nurse (quota). Clinical data were collected retrospectively through electronic records. Using cluster analysis, we identified two groups of units according to the score for each indicator. We calculated the Odds Ratio, adjusted for age sex, BMI, socioeconomic status and smoking, for complying with each recommendation whether a patient was treated by one of the quota from the highest score to the lowest. 30,312 patients with DM2 were identified: prevalence: 6.39%; coefficient of variation between UDN: 22.8%; biggest cluster 7.7% and smallest 5.3%; OR=1.54 (1.50-1.58). The HbA1c control at ≤8% was 82.8% (82.2-83.3) and >9% was 7.6% (7.3-8.0), with OR 1.79 (1.69-1.89) and 2.62 (2.36-2.91) respectively. Control of BP and LDL-C show significant differences between the clusters.
An important variability was identified according to the doctor treating patients. The average HbA1c control is acceptable being limited in BP and LDL-C.
由在西班牙纳瓦拉提供初级保健服务的医生和护士群体,评估2型糖尿病(DM2)患者对国际糖尿病联盟(IDF)建议的依从性及其变异性。
对2013年年龄≥18岁的462568名居民进行横断面研究,由381个医生/护士单元(配额)参与。通过电子记录回顾性收集临床数据。使用聚类分析,我们根据每个指标的得分确定了两组单元。我们计算了比值比,并针对年龄、性别、体重指数、社会经济状况和吸烟情况进行了调整,以确定患者是否由得分从高到低的配额之一进行治疗时对每项建议的依从性。共识别出30312例DM2患者:患病率为6.39%;不同单元间的变异系数为22.8%;最大聚类为7.7%,最小聚类为5.3%;比值比=1.54(1.50 - 1.58)。糖化血红蛋白(HbA1c)控制在≤8%的比例为82.8%(82.2 - 83.3),>9%的比例为7.6%(7.3 - 8.0),比值比分别为1.79(1.69 - 1.89)和2.62(2.36 - 2.91)。血压和低密度脂蛋白胆固醇(LDL - C)的控制在各聚类之间存在显著差异。
根据治疗患者的医生不同,发现了重要的变异性。糖化血红蛋白的平均控制情况尚可,但血压和低密度脂蛋白胆固醇的控制有限。